ÂÜÀòÂÒÂ×

Karin Conde-Knape is a highly experienced individual who has held various leadership positions in reputable pharmaceutical companies such as Novo Nordisk, Johnson and Johnson Medical, and Roche. Currently serving as the Senior Vice President Global Drug Discovery at Novo Nordisk, Karin is responsible for research therapeutic area strategy and execution in the areas of Diabetes, Cardiovascular, Kidney disease, and translational science. With a post-doc degree in Lipids and Lipoproteins from Columbia University Vagelos College of Physicians and Surgeons, Karin has a strong background in research and in vivo pharmacology.